New Vice Chair Sharepoint
We have launched our new Department of Medicine Vice Chair SharePoint. This site will serve as a central hub for communications and materials from the… Read More »New Vice Chair Sharepoint
Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial
ARTICLE: Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial AUTHORS: Kelly E Dooley, Richard Kaplan, Noluthando Mwelase, Beatriz… Read More »Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial
Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes
ARTICLE: Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes AUTHORS: Marie-Pierre St-Onge, Brooke Aggarwal, Matthew A Allison, Jeffrey S Berger, Sheila F Castañeda, Janet… Read More »Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes
Epic Tip of the Week: March 19, 2021
Inpatient & Ambulatory: Personalization Freeze Prior to Epic Upgrade [Effective 3/21/21] During the personalization freeze users will be unable to customize their workflows. The personalization… Read More »Epic Tip of the Week: March 19, 2021
Match Day 2021
We are proud to present the 2021 intern class for the residency programs within the Department of Medicine. All members of this internship class are… Read More »Match Day 2021
Levine to Step Down as Associate Vice Chair for Women’s Careers in Academic Medicine
We are in search of our next associate vice chair for women’s careers in academic medicine and chair of the DOM Task Force on Women's… Read More »Levine to Step Down as Associate Vice Chair for Women’s Careers in Academic Medicine
Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study
ARTICLE: Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study AUTHORS: Christine M Durand, Brittany Barnaba, Sile… Read More »Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
ARTICLE: Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial AUTHORS: Kelly E Dooley, Radojkam Savic, Akshay… Read More »Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
2021 DOM/WSE Research Retreat Recap
Thank you to everyone who participated in the 2021 Department of Medicine/Whiting School of Engineering Research Retreat. Our first-ever, two-day virtual event was a challenge… Read More »2021 DOM/WSE Research Retreat Recap
Beach Named Director of Medical Student Research and Scholarship
Dr. Mary Catherine Beach, professor in the Division of General Internal Medicine, has been named the inaugural director of medical student research and scholarship for… Read More »Beach Named Director of Medical Student Research and Scholarship